BioSpace News Archive

Drug Development

FDA Grants Genentech’s Alectinib Priority Review For Specific Type Of ALK-Positive Lung Cancer

September 9, 2015
·
5 min read
Business

Alzheon Appoints Susan Abushakra, M.D., As Chief Medical Officer

September 9, 2015
·
1 min read
Business

Asuragen, Inc. To Collaborate With Illumina On Companion Diagnostics Development

September 9, 2015
·
2 min read
Policy

Chugai’s ALK Inhibitor “Alectinib,” New Drug Application Submitted For ALK Positive Advanced Non-Small Cell Lung Cancer In The United States

September 9, 2015
·
5 min read
BioMidwest

Blue Belt Technologies, Inc. Announces First Navio Case Utilizing Smith & Nephew plc’s ZUK Unicompartmental Knee

September 9, 2015
·
3 min read
Business

Opko Health Announces Global License Agreement For The Discovery Of Novel Antimicrobials

September 9, 2015
·
4 min read
BioForest

Starnes’ Physician-Sponsored IDE Study Gains FDA Approval To Add More AAA Devices & Introduce Planning Tool

September 9, 2015
·
5 min read
Drug Development

AstraZeneca PLC Presents Further Evidence For The Potential Of AZD9291 In First-Line And Pre-Treated Non-Small Cell Lung Cancer

September 9, 2015
·
7 min read
Genetown

Exosome Diagnostics Presents Clinical Performance Data For Exodx Lung(ALK) Liquid Biopsy Test And New Data On Detection Of EGFR Activating Mutations And T790M Resistance Mutation

September 9, 2015
·
6 min read
Drug Development

Seattle Genetics Completes Enrollment In Phase III ALCANZA Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) In CD30-Expressing Cutaneous T-Cell Lymphoma (CTCL)

September 9, 2015
·
16 min read